[Federal Register Volume 74, Number 63 (Friday, April 3, 2009)]
[Pages 15296-15297]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7704]



National Institutes of Health

Notice of a Conference Call of a Working Group of the NIH Blue 
Ribbon Panel

    The purpose of this notice is to inform the public about a 
conference call of the NIH Blue Ribbon Panel to Advise on the Risk 
Assessment of the National Emerging Infectious Diseases Laboratories at 
Boston University Medical Center. This meeting is the first in a series 
of public meetings to review and discuss the ongoing supplementary risk 
assessment study.
    The conference call will be held on Tuesday, April 7, 2009 from 
approximately 11 a.m. to 1 p.m. The toll-free number to participate in 
the call is 1-800-779-2616. Indicate to the conference operator that 
your participant passcode is ``NIH.''
    The panel will review earlier National Research Council (NRC) 
recommendations regarding a supplementary risk assessment study, Blue 
Ribbon Panel recommendations regarding various aspects of the risk 
assessment study, and a new Statement of Task for the NRC.
    Public comment will begin at approximately 12:45 p.m. In the event 
that time does not allow for all those interested to present oral 
comments, anyone may file written comments by sending them to the 
address below. Comments should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the commenter.
    A draft agenda and slides for the meeting may be obtained by 
connecting to http://nihblueribbonpanel-bumc-

[[Page 15297]]

neidl.od.nih.gov/. For additional information concerning this meeting, 
contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of 
Biotechnology Activities, Office of Science Policy, Office of the 
Director, National Institutes of Health, 6705 Rockledge Drive, Room 
750, Bethesda, MD 20892-7985; telephone 301-496-9838; e-mail 
[email protected].

    Dated: March 31, 2009.
Amy P. Patterson,
Acting Director, Office of Science Policy, National Institutes of 
[FR Doc. E9-7704 Filed 4-2-09; 8:45 am]